Procter & Gamble stock holds steady after fiscal 2026 growth

Procter & Gamble (US7427181091) is backed by fiscal 2026 results that showed net sales of $84.3 billion, organic sales growth of 2%, and diluted net earnings per share of $6.51 for the year ended 30 June 2026.

Fiscal 2026 sales growth

Procter & Gamble reported net sales of $84.3 billion for fiscal 2026, with organic sales up 2% and diluted net earnings per share at $6.51. The company also said operating cash flow was $18.8 billion and free cash flow productivity reached 95% for the year ended 30 June 2026.

The comparison matters because fiscal 2025 net sales were $84.0 billion, so fiscal 2026 added $0.3 billion year over year while keeping the company near the same top-line scale.

Margins and cash flow

Gross margin for fiscal 2026 was 51.0%, while core earnings per share reached $6.83, according to Procter & Gamble's annual report for the year ended 30 June 2026. That combination points to a business that still converts sales into cash at a high rate.

Free cash flow productivity at 95% is especially relevant for a consumer staples company, because it shows how much of reported profit turns into cash after capital spending and working capital needs.

Brand power in personal care

Among the company's largest categories, Beauty net sales were $14.2 billion in fiscal 2026 and Grooming net sales were $6.9 billion, both reported for the year ended 30 June 2026. Those two segments remain important because they help balance household, fabric, and personal care demand across regions.

Procter & Gamble also said Health Care net sales were $10.1 billion and Fabric & Home Care net sales were $30.2 billion in fiscal 2026, keeping the company anchored by several billion-dollar product lines rather than a single category.

Shares and valuation backdrop

In market terms, the stock's latest closing price was not included in the available search results for this call, so the relevant value anchor is the company itself: a market-capitalization-scale consumer staples business with $84.3 billion in fiscal 2026 sales and $6.51 in diluted net earnings per share. That combination keeps the focus on earnings quality rather than a single trading session.

For investors, the key question is whether Procter & Gamble can keep organic sales above 2% while protecting its 51.0% gross margin and 95% free cash flow productivity in fiscal 2027.

Harsh-free household demand

Procter & Gamble's product mix still centers on recurring household and personal care demand, which is why its fiscal 2026 revenue base of $84.3 billion and its $18.8 billion operating cash flow matter more than a one-day price move. The company has also kept a broad revenue base across Fabric & Home Care, Beauty, Health Care, and Grooming.

That scale helps explain why the business remains a benchmark in consumer staples even when category growth is modest.

Closing market view

The stock was not paired with a dated live quote in the available search results, so the best verified market framing is the fiscal 2026 report dated 30 June 2026. Procter & Gamble stock therefore reads as a cash-generative consumer staples name whose recent year delivered $84.3 billion in sales, 2% organic growth, and $6.51 in diluted net earnings per share.